Page 4 - Les meilleurs doctors traitant la maladie suivante : Cancer de l'oesophage - TOP -133 des médecins

Le professeur associé Nail Paksoy est spécialisé dans le traitement du cancer de l'œsophage à l'hôpital Medipol Bahçelievler, avec une vaste expérience en recherche et en essais cliniques.

• Certifié par l'ESMO en oncologie médicale
• Participation à 8 essais cliniques internationaux pour divers cancers
• Publication de plusieurs études sur les résultats des traitements contre le cancer
• Formation spécialisée à l'Institut d'oncologie de l'Université d'Istanbul

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Le Dr Ozden est spécialisé dans le traitement du cancer de l'œsophage et possède une vaste formation en oncologie médicale.

• Diplômé de la faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Spécialisation en oncologie médicale à l'université de Kocaeli
• Plus de dix ans d'expérience en médecine interne et en oncologie
• Exerce à l'hôpital VM Medical Park Pendik

Plus de 30 ans d'expérience en immunologie avec une spécialisation en virothérapie – Le Dr Jaunalksne apporte son expertise de pointe en immunothérapie au traitement du cancer de l'œsophage.

• Se spécialiser en virothérapie, une approche novatrice du traitement du cancer
• Diriger le centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Être diplômé de l'Institut médical de Riga

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Le professeur Gul Alco est spécialisé en radio-oncologie avec plus de 20 ans d'expérience, exerçant actuellement à l'Université Medipol d'Istanbul.

• Formée à l'Université d'Istanbul et à l'Université Kadir Has
• Professeur agrégé puis Professeur à l'Université Demiroglu Bilim
• Experte en radio-oncologie pour le traitement du cancer
• Travaille à l'hôpital de district Medipol Acibadem

Le Dr Muzaffer Al est spécialisé dans la chirurgie laparoscopique avancée et oncologique, avec une formation approfondie dans les meilleures institutions médicales.

• Être formé en chirurgie laparoscopique à la faculté de médecine Çapa de l'Université d'Istanbul
• Être spécialisé en chirurgie laparoscopique antireflux et en chirurgie bariatrique laparoscopique avancée
• Avoir de l'expérience en chirurgie oncologique, y compris le cancer de l'œsophage

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Ezgi Sevic est spécialisée en nutrition pour les patients atteints de cancer, notamment le cancer de l'œsophage. Elle est diplômée avec mention de l'Université Hacettepe.

• Réaliser des études sur l'insulinorésistance et l'obésité
• Travailler dans des hôpitaux d'oncologie et des centres de santé communautaire
• Expertiser en nutrition post-chirurgie bariatrique
• Maîtriser l'anglais à un niveau avancé pour les patients internationaux

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Spécialisé en chirurgie oncologique avec une expertise dans le cancer de l'œsophage aux hôpitaux Büyük Anadolu.

• Expérimenté dans les chirurgies du pancréas et des voies biliaires
• Compétent dans les procédures du cancer gastrique et du côlon
• Réaliser des chirurgies bariatriques métaboliques et du diabète

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Plus de 15 000 interventions chirurgicales pratiquées – le Dr de Lacy est un pionnier des techniques mini-invasives pour le cancer de l'œsophage à l'Hôpital Quiron Barcelone.

• Réaliser plus de 1 000 interventions par an en utilisant des méthodes laparoscopiques et robotisées
• Président de l'Association des chirurgiens-endoscopistes en Europe
• Pionnier de renommée mondiale dans les techniques de chirurgie gastro-intestinale
• Conférencier sur la laparoscopie avancée et les techniques chirurgicales

Le Professeur Keun Chil Park, MD, dirige le département d'hématologie-oncologie du Samsung Medical Center, avec une expertise particulière dans le cancer de l'œsophage.

• Intérêts spécifiques pour les cancers du poumon, de la tête et du cou, et de l'œsophage
• Membre de plusieurs associations d'oncologie prestigieuses, notamment l'ASCO et l'ESMO
• Diplômé de la Faculté de Médecine de l'Université Nationale de Séoul

Le Dr Choi Yong Soo est un chirurgien thoracique au Samsung Medical Center, spécialisé dans le traitement du cancer de l'œsophage.

• Expert en interventions chirurgicales pour les cas complexes de cancer de l'œsophage
• Exerce dans l'une des principales institutions médicales de Corée du Sud
• Se concentre sur l'élaboration de plans de traitement personnalisés

Le professeur Haciibrahimoglu se spécialise en oncologie chirurgicale thoracique, y compris le cancer de l'œsophage, avec une expertise en chirurgie thoracoscopique vidéo-assistée (VATS).

• Formation à l'Université Paris-Sud et à l'École de médecine de Vienne
• Plus de 20 ans d'expérience en chirurgie thoracique
• Membre de la Société européenne des chirurgiens thoraciques
• Publication de 13 articles internationaux sur la chirurgie thoracique